IL75490A0 - Controlled release pharmaceutical compositions containing solid dispersions of active agent - Google Patents

Controlled release pharmaceutical compositions containing solid dispersions of active agent

Info

Publication number
IL75490A0
IL75490A0 IL75490A IL7549085A IL75490A0 IL 75490 A0 IL75490 A0 IL 75490A0 IL 75490 A IL75490 A IL 75490A IL 7549085 A IL7549085 A IL 7549085A IL 75490 A0 IL75490 A0 IL 75490A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
active agent
controlled release
compositions containing
containing solid
Prior art date
Application number
IL75490A
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL75490A0 publication Critical patent/IL75490A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL75490A 1984-06-14 1985-06-12 Controlled release pharmaceutical compositions containing solid dispersions of active agent IL75490A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3442566 1984-11-22

Publications (1)

Publication Number Publication Date
IL75490A0 true IL75490A0 (en) 1985-10-31

Family

ID=25822108

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75490A IL75490A0 (en) 1984-06-14 1985-06-12 Controlled release pharmaceutical compositions containing solid dispersions of active agent

Country Status (21)

Country Link
AT (1) AT391806B (en)
AU (2) AU587190B2 (en)
BE (1) BE902626A (en)
CA (1) CA1264441A (en)
CY (1) CY1635A (en)
DE (1) DE3520184C2 (en)
DK (1) DK167649B1 (en)
ES (1) ES8702141A1 (en)
FR (1) FR2565822B1 (en)
GB (3) GB2160100B (en)
GR (1) GR851430B (en)
HK (1) HK25192A (en)
HU (1) HU198844B (en)
IE (1) IE58834B1 (en)
IL (1) IL75490A0 (en)
IT (1) IT1200080B (en)
LU (1) LU85946A1 (en)
NL (1) NL194389C (en)
NZ (1) NZ212390A (en)
PT (1) PT80635B (en)
SE (1) SE504583C2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (en) * 1985-10-15 1987-12-23 Eurand Spa PROCEDURE FOR THE PREPARATION OF SOLID FORMULATIONS OF NIFEDIPINE WITH HIGH BIO AVAILABILITY AND WITH PROLONGED EFFECT AND FORMULATIONS SO OBTAINED
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
AU3432689A (en) * 1988-03-24 1989-10-16 Bukh Meditec A/S Controlled release composition
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
DK469989D0 (en) * 1989-09-22 1989-09-22 Bukh Meditec PHARMACEUTICAL PREPARATION
MX9300110A (en) * 1992-01-13 1994-07-29 Gerhard Gergely PHARMACEUTICAL PREPARATION IN THE FORM OF AN EFFERVESCENCE OR DISINTEGRATION TABLET OR OF AN INSTANT-TYPE GRANULATE AND PROCEDURE FOR ITS PREPARATION.
DE4201179A1 (en) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Granulates or pellets comprising dispersion of active agent in hydrophilic macromolecules - are e.g. for treatment of depression, hypertension, rheumatism, etc.
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
AU695734B2 (en) * 1996-07-08 1998-08-20 Penwest Pharmaceuticals Co. Sustained release matrix for high-dose insoluble drugs
DE19710009A1 (en) * 1997-03-12 1998-09-24 Knoll Ag Multi-phase preparation forms containing active ingredients
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
WO2000076480A2 (en) * 1999-06-11 2000-12-21 Eli Lilly And Company Pharmaceutical materials and methods for their preparation and use
RU2220715C2 (en) * 1999-08-04 2004-01-10 Яманоути Фармасьютикал Ко., Лтд. Stable peroral gel-forming pharmaceutical composition, method for it preparing, method for prevention alteration in medicinal agent releasing, method for enhancement of physical stability of peroral composition
ES2304980T3 (en) 1999-09-30 2008-11-01 Penwest Pharmaceuticals Co. SUSTAINED LIBERATION MATRIX SYSTEMS FOR HIGHLY SOLUBLE PHARMACOS.
EP1361868A1 (en) * 2001-02-13 2003-11-19 AstraZeneca AB Novel modified release formulation
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (en) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Process for the preparation of dosage forms comprising a solid dispersion of a microcrystalline active agent
US8956602B2 (en) 2006-12-05 2015-02-17 Landec, Inc. Delivery of drugs
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
US9192578B2 (en) * 2008-08-20 2015-11-24 Board Of Regents, The University Of Texas System Hot-melt extrusion of modified release multi-particulates

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (en) * 1967-11-17 1971-03-25 Beiersdorf Ag Process for the production of medicaments with delayed release of active substances in the form of capsules
DE2400819C2 (en) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Process for the production of solid preparations of poorly soluble active pharmaceutical ingredients in extremely fine distribution
DE2546577B2 (en) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Solid substances made from polyvinylpyrrolidone and ergot alkaloids
GB1504553A (en) * 1975-11-17 1978-03-22 Sandoz Ltd Tablet formulations
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
DK149855C (en) * 1977-06-20 1987-04-21 Sandoz Ag METHOD OF ANALOGY FOR THE PREPARATION OF 1,4-DIHYDROPYRIDINE DERIVATIVES
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
FI793888A (en) * 1978-12-21 1980-06-22 Sandoz Ag GALENISKA BLANDNINGAR
DE2904310A1 (en) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh MOLDINGS WITH RETARDED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (en) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen SOLID PHARMACEUTICAL PREPARATIONS CONTAINING NIFEDIPINE AND METHOD FOR THE PRODUCTION THEREOF
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
DE3318649A1 (en) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen TWO-PHASE FORMULATION

Also Published As

Publication number Publication date
SE504583C2 (en) 1997-03-10
SE8502950D0 (en) 1985-06-13
FR2565822B1 (en) 1989-02-17
AT391806B (en) 1990-12-10
IE851460L (en) 1985-12-14
HU198844B (en) 1989-12-28
GB2196852A (en) 1988-05-11
NL194389C (en) 2002-03-04
DE3520184A1 (en) 1985-12-19
ATA174885A (en) 1990-06-15
PT80635A (en) 1985-07-01
NL194389B (en) 2001-11-01
ES544075A0 (en) 1987-01-01
FR2565822A1 (en) 1985-12-20
BE902626A (en) 1985-12-10
IT8548210A0 (en) 1985-06-13
SE8502950L (en) 1985-12-15
GR851430B (en) 1985-11-25
IT1200080B (en) 1989-01-05
GB8727056D0 (en) 1987-12-23
AU4454389A (en) 1990-03-22
GB2196851B (en) 1989-06-07
DK264785D0 (en) 1985-06-12
NL8501578A (en) 1986-01-02
DK264785A (en) 1985-12-15
GB8727055D0 (en) 1987-12-23
PT80635B (en) 1987-10-20
CY1635A (en) 1992-11-06
DE3520184C2 (en) 1997-03-13
CA1264441A (en) 1990-01-16
HUT40918A (en) 1987-03-30
DK167649B1 (en) 1993-12-06
GB2196852B (en) 1989-05-17
NZ212390A (en) 1992-02-25
GB2160100A (en) 1985-12-18
AU587190B2 (en) 1989-08-10
GB8514855D0 (en) 1985-07-17
GB2160100B (en) 1989-06-01
ES8702141A1 (en) 1987-01-01
HK25192A (en) 1992-04-10
IE58834B1 (en) 1993-11-17
GB2196851A (en) 1988-05-11
AU4348685A (en) 1985-12-19
LU85946A1 (en) 1986-01-24

Similar Documents

Publication Publication Date Title
IL75490A0 (en) Controlled release pharmaceutical compositions containing solid dispersions of active agent
EP0224146A3 (en) Pharmaceutical preparation for the controlled release of active ingredients
EP0467488A3 (en) Composition for the controlled discharge of an active ingredient
GB8502974D0 (en) Sustained release of active substance
PT81746A (en) Process for the preparation of peptide-aldehydes and of pharmaceutical compositions containing them
GB2143734B (en) Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content
GB2120937B (en) Implant for sustained release of pharmaceutical agents
DE3571924D1 (en) Dosage units for controlled release of active material
PT81502A (en) Process for the preparation of cholecalciferol derivatives and of pharmaceutical compositions containing the same
PT80794A (en) Process for the preparation of novel isoindolinyl-alkyl-piperazines and of pharmaceutical compositions containing the same
PT79858A (en) Process for the preparation of azolyl-aryl-alcanol and pharmaceutical compositions therewith
EP0277740A3 (en) Aqueous film-forming compositions for controlling the release of active agents and process of making same
GB2181053B (en) Pharmaceutical formulations with controlled release of the active substance
HUT39450A (en) Process for producing imidazobicyclic compounds and pharmaceutical compositions containing them as active agents
PT81083A (en) Process for the preparation of substituted 7-oxomitosanes and of pharmaceutical compositions containing the same
PT80315B (en) Process for the preparation of imidazole derivatives and of pharmaceutical compositions containing the same
GB2161382B (en) Pharmaceutical and cosmetic compositions containing 1 8-dihydroxy-10-phenyl-9-anthrone and process for the preparation of this compound
IL64827A0 (en) Fungicidal compositions containing certain amino acid derivatives and the preparation of these derivatives
HUT35924A (en) Fungicide composition or regulated release of active agents
PT75281A (en) Process for the preparation of biologically active hydrazonocephem derivatives and of pharmaceutical compositions containing the same
PT83456A (en) Process for the preparation of pharmaceutical compositions with controlled release of active substance
PT79990B (en) Process for the preparation of diazepine-indoles and of pharmaceutical compositions therewith
IL74459A (en) Controlled release pharmaceutical compositions containing bromocriptine
HUT37785A (en) Process for producing 3-alkoxy-2-pyrrolidino-n-pyrimidinyl-or -n-pyrazinyl-propyl-amines and pharmaceutical compositions containing them as active agents
HU906363D0 (en) Herbicide compositions containing n-amino-triazole-derivatives and process for the preparation of the active agents

Legal Events

Date Code Title Description
RH Patent void